Trials / Sponsors / Novakand Pharma AB
Novakand Pharma AB
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Vo Ovarian Cancer | Phase 1 | 2023-11-09 |
| Completed | A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Ep Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer | Phase 1 / Phase 2 | 2023-04-26 |
| Terminated | KAND567 Versus Placebo in Subjects Hospitalized With COVID-19 Covid19 | Phase 2 | 2020-10-11 |
| Completed | Safety, Tolerability and Pharmacokinetics After Continuous Infusion of KAND567 Healthy | Phase 1 | 2020-02-17 |